These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 14567797)

  • 1. A widely applicable, high-throughput TR-FRET assay for the measurement of kinase autophosphorylation: VEGFR-2 as a prototype.
    Moshinsky DJ; Ruslim L; Blake RA; Tang F
    J Biomol Screen; 2003 Aug; 8(4):447-52. PubMed ID: 14567797
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Establishment of homogeneous time-resolved fluorescence immunoassay for high throughput screening of protein tyrosine kinase inhibitors].
    Li XG; Wang GF; Zhang JY; Wu SY; Xu W; Wu SG; Zhang JJ
    Nan Fang Yi Ke Da Xue Xue Bao; 2009 Aug; 29(8):1612-4. PubMed ID: 19726307
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of miniaturized time-resolved fluorescence resonance energy transfer and enzyme-coupled luciferase high-throughput screening assays to discover inhibitors of Rho-kinase II (ROCK-II).
    Schröter T; Minond D; Weiser A; Dao C; Habel J; Spicer T; Chase P; Baillargeon P; Scampavia L; Schürer S; Chung C; Mader C; Southern M; Tsinoremas N; LoGrasso P; Hodder P
    J Biomol Screen; 2008 Jan; 13(1):17-28. PubMed ID: 18227223
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of high-throughput TR-FRET and AlphaScreen assays for identification of potent inhibitors of PDK1.
    Xu Z; Nagashima K; Sun D; Rush T; Northrup A; Andersen JN; Kariv I; Bobkova EV
    J Biomol Screen; 2009 Dec; 14(10):1257-62. PubMed ID: 19822882
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and applications of a broad-coverage, TR-FRET-based kinase binding assay platform.
    Lebakken CS; Riddle SM; Singh U; Frazee WJ; Eliason HC; Gao Y; Reichling LJ; Marks BD; Vogel KW
    J Biomol Screen; 2009 Sep; 14(8):924-35. PubMed ID: 19564447
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological characterization of CP-547,632, a novel vascular endothelial growth factor receptor-2 tyrosine kinase inhibitor for cancer therapy.
    Beebe JS; Jani JP; Knauth E; Goodwin P; Higdon C; Rossi AM; Emerson E; Finkelstein M; Floyd E; Harriman S; Atherton J; Hillerman S; Soderstrom C; Kou K; Gant T; Noe MC; Foster B; Rastinejad F; Marx MA; Schaeffer T; Whalen PM; Roberts WG
    Cancer Res; 2003 Nov; 63(21):7301-9. PubMed ID: 14612527
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization and development of a peptide substrate-based phosphate transfer assay for the human vascular endothelial growth factor receptor-2 tyrosine kinase.
    Zhao G; Peery RB; Yingling JM
    Anal Biochem; 2007 Jan; 360(2):196-206. PubMed ID: 17141171
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Time-resolved fluorescence resonance energy transfer as a versatile tool in the development of homogeneous cellular kinase assays.
    Saville L; Spais C; Mason JL; Albom MS; Murthy S; Meyer SL; Ator MA; Angeles TS; Husten J
    Assay Drug Dev Technol; 2012 Dec; 10(6):551-7. PubMed ID: 22428805
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Utilization of fluorescence polarization and time resolved fluorescence resonance energy transfer assay formats for SAR studies: Src kinase as a model system.
    Newman M; Josiah S
    J Biomol Screen; 2004 Sep; 9(6):525-32. PubMed ID: 15452339
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assay concordance between SPA and TR-FRET in high-throughput screening.
    von Ahsen O; Schmidt A; Klotz M; Parczyk K
    J Biomol Screen; 2006 Sep; 11(6):606-16. PubMed ID: 16760369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of an AlphaScreen-based high-throughput screening assay for inhibitors of human vascular endothelial growth factor receptor-3.
    Wang K; Yang R; Xu J; Zhang Y; Zhu L; Lin J; Huang B
    J Immunoassay Immunochem; 2011; 32(3):219-32. PubMed ID: 21574093
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Dual Readout Assay Based on Fluorescence Polarization and Time-Resolved Fluorescence Resonance Energy Transfer to Screen for RSK1 Inhibitors.
    Jeong EM; Lee MY; Lee JH; Lee BH; Oh KS
    Biol Pharm Bull; 2016; 39(4):547-55. PubMed ID: 27040627
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of a time-resolved fluorescence resonance energy transfer assay (cell TR-FRET) for protein detection on intact cells.
    Lundin K; Blomberg K; Nordström T; Lindqvist C
    Anal Biochem; 2001 Dec; 299(1):92-7. PubMed ID: 11726189
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A fluorescence resonance energy transfer-based binding assay for characterizing kinase inhibitors: important role for C-terminal biotin tagging of the kinase.
    Kwan J; Ling A; Papp E; Shaw D; Bradshaw JM
    Anal Biochem; 2009 Dec; 395(2):256-62. PubMed ID: 19716360
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and comparison of nonradioactive in vitro kinase assays for NIMA-related kinase 2.
    Jin G; Aulabaugh A; Pocas J; Liu H; Kriz R; Sampath D
    Anal Biochem; 2006 Nov; 358(1):59-69. PubMed ID: 16962550
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of Receptor Tyrosine Kinase Inhibitors Using Cell Surface Biotinylation and Affinity Isolation.
    Latham AM; Kankanala J; Fishwick CW; Ponnambalam S
    Methods Mol Biol; 2015; 1332():121-31. PubMed ID: 26285749
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fluorescence polarization and time-resolved fluorescence resonance energy transfer techniques for PI3K assays.
    Horiuchi KY; Ma H
    Methods Mol Biol; 2009; 572():161-76. PubMed ID: 20694691
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A selective and oral small molecule inhibitor of vascular epithelial growth factor receptor (VEGFR)-2 and VEGFR-1 inhibits neovascularization and vascular permeability.
    Patel N; Sun L; Moshinsky D; Chen H; Leahy KM; Le P; Moss KG; Wang X; Rice A; Tam D; Laird AD; Yu X; Zhang Q; Tang C; McMahon G; Howlett A
    J Pharmacol Exp Ther; 2003 Sep; 306(3):838-45. PubMed ID: 12766257
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CEP-7055: a novel, orally active pan inhibitor of vascular endothelial growth factor receptor tyrosine kinases with potent antiangiogenic activity and antitumor efficacy in preclinical models.
    Ruggeri B; Singh J; Gingrich D; Angeles T; Albom M; Yang S; Chang H; Robinson C; Hunter K; Dobrzanski P; Jones-Bolin S; Pritchard S; Aimone L; Klein-Szanto A; Herbert JM; Bono F; Schaeffer P; Casellas P; Bourie B; Pili R; Isaacs J; Ator M; Hudkins R; Vaught J; Mallamo J; Dionne C
    Cancer Res; 2003 Sep; 63(18):5978-91. PubMed ID: 14522925
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Time-resolved fluorescence resonance energy transfer kinase assays using physiological protein substrates: applications of terbium-fluorescein and terbium-green fluorescent protein fluorescence resonance energy transfer pairs.
    Riddle SM; Vedvik KL; Hanson GT; Vogel KW
    Anal Biochem; 2006 Sep; 356(1):108-16. PubMed ID: 16797477
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.